DarioHealth (DRIO) Tops Q1 EPS by 62c

DarioHealth (NASDAQ: DRIO) reported Q1 EPS of $0.20, $0.62 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $5.76 million versus the consensus estimate of $5.82 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c